Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Aims/hypothesis Non-alcoholic fatty liver disease (NAFLD) has been associated with the metabolic syndrome. However, it is not clear whether insulin resistance is an independent feature of NAFLD, and it remains to be determined which of the in vivo actions of insulin are impaired in this condition.Methods We performed a two-step (1.5 and 6 pmol min(-1) kg(-1)) euglycaemic insulin clamp coupled with tracer infusion ([6,6-2H2]glucose and [2H5]glycerol) and indirect calorimetry in 12 non-obese, normolipidaemic, normotensive, non-diabetic patients with biopsy-proven NAFLD and six control subjects.Results In NAFLD patients, endogenous glucose production (basal and during the clamp) was normal; however, peripheral glucose disposal was markedly decreased (by 30% and 45% at the low and high insulin doses, respectively, p<0.0001) at higher plasma insulin levels (p=0.05), due to impaired glucose oxidation (p=0.003) and glycogen synthesis (p<0.001). Compared with control subjects, glycerol appearance and lipid oxidation were significantly increased in NAFLD patients in the basal state, and were suppressed by insulin to a lesser extent (p<0.05-0.001). The lag phase of the in vitro copper-catalysed peroxidation of LDL particles was significantly shorter in the patients than in the control subjects (48+/-12 vs 63+/-13 min, p<0.04). Lipid oxidation was significantly related to endogenous glucose production, glucose disposal, the degree of hepatic steatosis, and LDL oxidisability.Conclusions/interpretation Insulin resistance appears to be an intrinsic defect in NAFLD, with the metabolic pattern observed indicating that adipose tissue is an important site.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, many studies have shown an increase in fatty acid oxidation and β-hydroxybutyrate in individuals with MASH compared to those without liver steatosis.,38,39 likely driven by the high fatty acid flux to the liver due to Adipo-IR.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [39]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
Self-citationLudwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Self-citation
Cited by
Items 501–600 of 790
Holleboom, A. G., Francque, S., Cusi, K. J., & Caussy, C. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100424 · Cited by 11
Dysfunctional adipose tissue–lymphatic crosstalk in obesity
Nardo, W. D., Chan, A. Y., Porter, C. J. H., Cao, E., & Trevaskis, N. L. (2026) · Nature Reviews Endocrinology · doi:10.1038/s41574-026-01243-y · Cited by 9
Koo, D.-J., & Lee, W. (2022) · Cardiovascular Prevention and Pharmacotherapy · doi:10.36011/cpp.2022.4.e17 · Cited by 9
Lemoine, M. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009370394 · Cited by 9
Non‐Alcoholic Fatty Liver Disease
Nikolopoulos, A., & Oben, J. A. (2009) · Wiley eBooks · doi:10.1002/9781444322682.ch8 · Cited by 9
Increased circulating adiponectin in males with chronic HCV hepatitis
Canavesi, E., Porzio, M., Ruscica, M., Rametta, R., Macchi, C., Pelusi, S., Fracanzani, A. L., Dongiovanni, P., Fargion, S. R., Magni, P., et al. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.08.001 · Cited by 9
The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease
Morio, R., Hyogo, H., Hatooka, M., Morio, K., Kan, H., Kobayashi, T., Kawaoka, T., Tsuge, M., Hiramatsu, A., Imamura, M., et al. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1236-7 · Cited by 9
Abbate, M., Montemayor, S., Mascaró, C. M., Casares, M., Gómez, C., Ugarriza, L., Tejada, S., Abete, I., Zulet, M. Á., Sureda, A., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10143187 · Cited by 9
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers
Terracciani, F., Falcomatà, A., Gallo, P., Picardi, A., & Gentilucci, U. V. (2022) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-022-00934-0 · Cited by 9
Purcell, A. R., & Glastras, S. J. (2023) · Nutrients · doi:10.3390/nu15092155 · Cited by 9
Review on Liver Steatosis and its Impact on Liver Transplantation
Ahmed, E. A. (2017) · Journal of Liver Research Disorders & Therapy · doi:10.15406/jlrdt.2017.03.00064 · Cited by 9
Prognostic value of non-alcoholic fatty liver disease in the elderly patients
Tallarico, V., Recinella, G., Magalotti, D., Muscari, A., Zoli, M., & Bianchi, G. P. (2020) · Aging Clinical and Experimental Research · doi:10.1007/s40520-020-01487-2 · Cited by 10
Montesi, L., Mazzotti, A., Moscatiello, S., Forlani, G., & Marchesini, G. (2013) · Hepatology International · doi:10.1007/s12072-013-9451-2 · Cited by 10
Liang, Y., Luo, S., Bell, S., Mo, J. M. Y., He, B., Zhou, Y., Bai, X., & Au Yeung, S. L. (2024) · BMC Medicine · doi:10.1186/s12916-024-03486-w · Cited by 8
“Our study is supported by previous observational and MR studies [4, 13–15, 42, 43] that genetic liability to T2D and FI likely increases the risk of liver steatosis and related biomarkers (e.g., ALT and PDFF), while liability to T2D appears to also increase the risk of liver cirrhosis.”
ResultEffect of Global ATGL Knockout on Murine Fasting Glucose Kinetics
Coelho, M., Nunes, P. M., Mendes, V. M., Manadas, B. J., Heerschap, A., & Jones, J. G. (2015) · Journal of Diabetes Research · doi:10.1155/2015/542029 · Cited by 8
The relationship of alanine aminotransferase to metabolic syndrome in a Korean population
Lee, S., Cho, D., Joo, N. S., Kim, K. M., & Kim, K. N. (2018) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2018.17333 · Cited by 8
Determinants of hepatic insulin clearance – Results from a Mendelian Randomization study
Lamprinou, A., Willmann, C., Machann, J., Schick, F., Eckstein, S. S., Man, C. D., VISENTIN, R., Birkenfeld, A. L., Peter, A., Stefan, N., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154776 · Cited by 8
Lorbek, G., & Rozm, D. (2012) · InTech eBooks · doi:10.5772/27316 · Cited by 8
Comprehensive Transcriptome Profiling of NAFLD- and NASH-Induced Skeletal Muscle Dysfunction
Guo, M., Xiang, L., Yao, J., Zhang, J., Zhu, S., Wang, D., Liu, C., Li, G., Wang, J., Gao, Y., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.851520 · Cited by 11
Li, N., Xang, W., Wu, S., Li, D., Chang, M., Xie, C., Zhang, M. Y., & Tan, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1173757 · Cited by 8
Clasen, F., Nunes, P. M., Bidkhori, G., Bah, N. K., Boeing, S., Shoaie, S., & Anastasiou, D. (2023) · iScience · doi:10.1016/j.isci.2023.106040 · Cited by 9
Downregulation of Hepatic Glucose‐6‐Phosphatase‐α in Patients With Hepatic Steatosis
Kotsias-Konopelska, S., Kienitz, T., & Quinkler, M. O. (2011) · Obesity · doi:10.1038/oby.2011.118 · Cited by 8
Practical management of the increasing burden of non-alcoholic fatty liver disease
Mouralidarane, A., Lin, C., Suleyman, N. M., Soeda, J., & Oben, J. A. (2010) · Frontline Gastroenterology · doi:10.1136/fg.2009.000935 · Cited by 9
Atherosclerosis and Liver Function Tests in Coronary Angiography Patients
Doğaner, Y. Ç., Rohrer, J. E., Aydoğan, Ü., Agerter, D. C., Cayci, T., & Barçın, C. (2015) · West Indian Medical Journal · doi:10.7727/wimj.2014.192 · Cited by 8
A System-Level Mechanism of Anmyungambi Decoction for Obesity: A Network Pharmacological Approach
Jang, D., Jeong, H., Kim, C.-E., & Leem, J. (2021) · Biomolecules · doi:10.3390/biom11121881 · Cited by 8
Martín‐Saladich, Q., Simó, R., Ciudin, A., Torres, J. B., Ramírez, C., Aguadé‐Bruix, S., Roque, A., Pizzi, M. N., Cuéllar, H., Rosón, N., et al. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70050 · Cited by 7
MASLD and the cardiovascular-kidney-liver-metabolic syndrome
Angelidi, A. M., Boutari, C., Kokkorakis, M., Stefanakis, K., Mikhailidis, D. P., Jacob, G., & Mantzoros, C. S. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag023 · Cited by 7
Gignac, T., Trépanier, G., Pradeau, M., Morissette, A., Agrinier, A.-L., Larose, É., Marois, J., Pilon, G., Gagnon, C., Vohl, M., et al. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00294.2023 · Cited by 8
Naiki‐Ito, A., Yeewa, R., Kuang, X., Taychaworaditsakul, W., Naiki, T., Kato, H., Nagayasu, Y., Chewonarin, T., & Takahashi, S. (2024) · Food & Function · doi:10.1039/d4fo00292j · Cited by 7
Israt, A. H., & Liaquat, A. (2016) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000688 · Cited by 8
GFD-Net: A novel semantic similarity methodology for the analysis of gene networks
Díaz–Montaña, J. J., Díaz–Díaz, N., & Gómez-Vela, F. (2017) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2017.02.013 · Cited by 9
Alam, S., Anam, K., Islam, S., Mustafa, G., Mamun, A. A., & Ahmad, N. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.06.011 · Cited by 7
Silva, V. M., Freitas, M., Xavier, S. A., Carvalho, P. B., Magalhães, J. T., Marinho, C. M. M., & Cotter, J. B. (2022) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000527027 · Cited by 7
Hernández‐Rodas, M. C., Jessica Morales, P., Rodrigo Valenzuela, B., Morales, G. I., & Alfonso Valenzuela, B. (2016) · Revista chilena de nutrición · doi:10.4067/s0717-75182016000200013 · Cited by 9
Etiopathogenesis of insulin resistance
Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820234-0.00010-x · Cited by 9
Wu, N., Zhai, X., Yuan, F., Li, J., Li, D., Wang, J., Zhang, L., Shi, Y. Y., Ji, G., He, G., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1026725 · Cited by 8
Expanding Pharmacists’ Role in the Management of Non-Alcoholic Fatty Liver Disease
Syed‐Abdul, M. M. (2023) · Pharmacy · doi:10.3390/pharmacy11050151 · Cited by 9
Yan, Y., & Zhang, W. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105772 · Cited by 7
Whelan, M., Wright, O. R. L., & Hickman, I. J. (2014) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2012.717975 · Cited by 8
Insulin Resistance in Nonalcoholic Fatty Liver Disease: Experience from Bangladesh
Azam, G., Alam, S., Hasan, S. N., Alam, S. M. N. E., Kabir, J., & Alam, A. K. (2016) · Bangladesh Critical Care Journal · doi:10.3329/bccj.v4i2.30022 · Cited by 7
Li, Y.-Y., Yu, Y., Jing, H. E., Gu, Y. H., Zhang, H., Bao, W.-P., Liu, C., Cao, L., & Fan, Y. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2602995 · Cited by 7
Misceo, D., Mocciaro, G., D’Amore, S., & Vacca, M. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-024-00871-3 · Cited by 7
Growth Hormone Promotes Hepatic Triglyceride Export in Humans
Baumgartner, C., Metz, M., Beghini, M., Pfleger, L., Tosin, A., Koldyka, O., Beiglböck, H., Fellinger, P., Vila, G., Luger, A., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf155 · Cited by 6
Self-citationHossain, I., Faruque, M., Akter, S., Bhuiyan, F., Rahman, M., & Ali, L. (2016) · Tropical Gastroenterology · doi:10.7869/tg.334 · Cited by 6
Thyroid dysfunction and insulin resistance in patients with nonalcoholic fatty liver disease
Assem, M., Fawzi, M., Ibrahim, A., & Saif, A. (2018) · The Egyptian Journal of Internal Medicine · doi:10.4103/ejim.ejim_3_18 · Cited by 7
Xu, S., Chen, L., Hong, D., Yang, L., Li, X., & Wang, X. (2020) · Gastroenterology Research and Practice · doi:10.1155/2020/3580840 · Cited by 7
Shiraishi, S., Liu, J., Saito, Y., Oba, Y., Nishihara, Y., & Yoshimura, S. (2024) · Biology · doi:10.3390/biology13020091 · Cited by 6
The therapeutic effects of berberine plus sitagliptin in a rat model of fatty liver disease.
Mehrdoost, S., Yaghmaei, P., Jafary, H., & Ebrahim‐Habibi, A. (2021) · PubMed Central · doi:10.22038/ijbms.2021.52239.11822 · Cited by 6
Mohseni, F., Rashvand, Z., Najafipour, R., Hadizadeh, S., & Moghbelinejad, S. (2016) · Biochemical Genetics · doi:10.1007/s10528-016-9747-8 · Cited by 6
Sharma, S., Stine, J. G., Verbeek, T., & Bezinover, D. (2022) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.07.020 · Cited by 5
Wang, Y., Zhang, Y., & Wang, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031051 · Cited by 6
Darcy, J., & Bartke, A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-25650-0_11 · Cited by 5
Zhang, X., Wang, Y., Qian, D., Wang, Z., Qin, Z., Liu, X., Liu, T., & Wang, B. (2018) · PubMed · Cited by 5
TCTP participates in hepatic metabolism by regulating gene expression involved in insulin resistance
Dong, K., Zhao, Q., Xue, Y., Wei, Y., Zhang, Y., & Yang, Y. (2020) · Gene · doi:10.1016/j.gene.2020.145263 · Cited by 5
Vittal, A., Shapses, M. A., Sharma, B., Sharma, D., Sun, Q., Sampson, M. L., Lee, W., Yakov, G. B., & Rotman, Y. (2020) · Hepatology Communications · doi:10.1002/hep4.1658 · Cited by 5
Cheng, F., Yun, S., Cao, J., Chang, M., Meng, J., Liu, J., Cheng, Y., & Feng, C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.700049 · Cited by 5
Osaki, A., Kagami, K., Ishinoda, Y., Sato, A., Kimura, T., Horii, S., Ito, K., Toya, T., Ido, Y., Namba, T., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076486 · Cited by 6
Tani, J., Masaki, T., Oura, K., Tadokoro, T., Morishita, A., & Kobara, H. (2024) · Microorganisms · doi:10.3390/microorganisms12091926 · Cited by 6
Alisi, A., Manco, M., Vito, R. D., & Nobili, V. (2010) · Springer eBooks · doi:10.1007/978-1-60327-874-4_15 · Cited by 5
Molecular Basis for Pathogenesis of Steatohepatitis: Contemporary Understanding and New Insights
Parkash, O., & Saeed, S. (2018) · InTech eBooks · doi:10.5772/intechopen.71405 · Cited by 5
Natural course of fatty liver in 36,195 South Korean adults
Sung, K., Lee, M.-Y., Lee, J., Lee, S.-H., Kim, Y. B., Song, W.-J., Huh, J.-H., Park, J., Shin, J., Seo, M. H., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44738-7 · Cited by 5
CHDH-PNPLA3 Gene–Gene Interactions Predict Insulin Resistance in Children with Obesity
Chiriță-Emandi, A., Șerban, C. L., Paul, C., Andreescu, N. I., Velea, I. P., Mihailescu, A., Serafim, V., Tiugan, D.-A., Tutac, P., Zimbru, C. G., et al. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s277268 · Cited by 5
Naguib, H., & Kassab, H. S. (2021) · Egyptian Liver Journal · doi:10.1186/s43066-021-00154-z · Cited by 5
Batyuk, L. V., & Kizilova, N. (2018) · Izdevniecība “Baltija Publishing” eBooks · doi:10.30525/978-9934-571-31-2 · Cited by 5
Kim, J., & Kim, E. (2012) · 대한지역사회영양학회지 · doi:10.5720/kjcn.2012.17.5.530 · Cited by 5
Hu, M., Sun, D., Yang, F., Zheng, X., Wu, N., Zhang, H., Yao, X.-D., Zhang, J.-H., & Zhang, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1505050 · Cited by 4
Prevalence of MASLD and fibrosis in Turkey: Results from a multicenter study of at-risk populations
Us, G. D., Innocenti, F., Koc, Ö. M., Yumuk, V., Öztürk, Z., & Koek, G. H. (2026) · PLoS ONE · doi:10.1371/journal.pone.0341214 · Cited by 4
Fatty liver disease, glucose tolerance and insulin resistance in obese adolescents
Slyper, A. H., Rosenberg, H., Kabra, A., Huang, W. ‐., Blech, B., & Matsumura, M. M. (2014) · Pediatric Obesity · doi:10.1111/ijpo.279 · Cited by 6
Korn, A., Nadeem, C., Bos, E. N., Niessen, H. W. M., Şimşek, S., & Krijnen, P. A. J. (2023) · Pathobiology · doi:10.1159/000531542 · Cited by 4
Yuenyong, I., Potue, P., Maneesai, P., Khamseekaew, J., Manimmanakorn, A., Iampanichakul, M., & Pakdeechote, P. (2025) · Life · doi:10.3390/life15030491 · Cited by 6
Mazhar, S. M., Patton, H. M., Scuderi, R. T., Yokoo, T., Faria, S. C., & Sirlin, C. B. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5449-8.00065-2 · Cited by 4
Lattuada, G., Radaelli, M. G., COBELLI, F. D., Esposito, A., Manzoni, G., Perra, S., Maschio, A. D., Castoldi, G., & Perseghin, G. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9796175 · Cited by 4
NAFLD and Insulin Resistance: A Multisystemic Disease
Gastaldelli, A. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_4 · Cited by 4
Self-citationProteomic analysis of fatty liver induced by starvation of medaka fish larvae
Ikeda, T., Ishikawa, T., Ninagawa, S., Okada, T., Ono, M., & Mori, K. (2023) · Cell Structure and Function · doi:10.1247/csf.23014 · Cited by 4
Wang, D., Zhang, J., Dai, H., Tong, K., Chen, M., Peng, J., & Huang, W. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2289045 · Cited by 4
Miao, Q., Sun, L., Wu, J., Zhu, X., Liu, J., Ruan, R. R., Huang, G., Mi, S., & Cheng, Y. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47060450 · Cited by 4
Ore, A., Akinloye, O. A., Adeogun, A. I., Ugbaja, R. N., Morifi, E., Makatini, M. M., Moepya, R. J., & Mbhele, T. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13836 · Cited by 6
Hepatic Biomarkers in Diabetes as Modulated by Dietary Phytochemicals
Basu, A., Basu, P., & Lyons, T. J. (2017) · Biomarkers in disease · doi:10.1007/978-94-007-7675-3_35 · Cited by 4
Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease
Kim, M. Y., & Baik, S. K. (2008) · The Korean Journal of Hepatology · doi:10.3350/kjhep.2008.14.1.1 · Cited by 5
Chalermchai, T., Hiransuthikul, N., Tangkijvanich, P., Pinyakorn, S., Avihingsanon, A., & Ananworanich, J. (2013) · AIDS Research and Therapy · doi:10.1186/1742-6405-10-21 · Cited by 7
Parola, M., & Pinzani, M. (2009) · Cited by 4
Nichtalkoholische Fettleber: Definition und Entstehung
Kacerovsky, M., & Roden, M. (2007) · Der Diabetologe · doi:10.1007/s11428-007-0130-6 · Cited by 4
microRNA-mediated resistance to hypoglycemia in the HepG2 human hepatoma cell line
Ueki, S., Murakami, Y., Yamada, S., Kimura, M., Saito, Y., & Saito, H. (2016) · BMC Cancer · doi:10.1186/s12885-016-2762-7 · Cited by 4
López‐Oliva, M. E., Garcimartín, A., & Muñoz-Martínez, E. (2017) · British Journal Of Nutrition · doi:10.1017/s000711451700232x · Cited by 4
Sarcopenia in Liver Disease: Current Evidence and Issues to Be sResolved
Song, M., Xia, L., Liu, Q., Sun, M., Wang, F., & Yang, C. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_19 · Cited by 5
Fouad, M. M., Fawzy, O., El-Aziz, S. A., Ibrahim, M. A., & Khidr, E. G. (2025) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2025.2603580 · Cited by 3
Epidemiology of Nonalcoholic Fatty Liver Disease (NAFLD)
Aithal, G. P., Das, K., & Chowdhury, A. (2014) · Wiley eBooks · doi:10.1002/9781118727072.ch32 · Cited by 4
Zyoud, S. H., Hegazi, O. E., Alalalmeh, S. O., Shakhshir, M. H., Abushamma, F., Khilfeh, S., & Al‐Jabi, S. W. (2024) · World Journal of Hepatology · doi:10.4254/wjh.v16.i6.951 · Cited by 3
Thapa, K., Ghimire, B. R., Pokharel, K., Cai, M., Savontaus, E., & Rinne, P. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01600-9 · Cited by 3
Kelty, T. J., Krause, A. A., & Rector, R. S. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00178.2025 · Cited by 4
Quantification of Insulin Action in Human Subjects
Krentz, A. J., Weyer, C., & Hompesch, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-11748-1_1 · Cited by 6
Fujita, T., Daimon, M., Mizushiri, S., Nishiya, Y., Murakami, H., Tanabe, J., Matsuhashi, Y., Yanagimachi, M., Tokuda, I., Sawada, K., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-72894-8 · Cited by 3
The transcontinental variability of nonalcoholic fatty liver disease
de Oliveira, C. P. M. S., Paredes, A. H., Siddiqui, M. S., Serfaty, L., Chowdhury, A., Stefano, J. T., Vanni, D. S., Boyett, S. L., & Sanyal, A. J. (2020) · Hepatoma Research · doi:10.20517/2394-5079.2020.73 · Cited by 3
Mojtahedi, K., Joukar, F., Fahim, S., Yeganeh, S., Asgharnezhad, M., Shafaghi, A., Asl, S. F., & Mansour‐Ghanaei, F. (2023) · Bulletin of Pharmaceutical Sciences Assiut · doi:10.21608/bfsa.2023.177224.1590 · Cited by 5
Niltwat, S., Limwongse, C., Charatcharoenwitthaya, N., Bunditvorapoom, D., Bandidniyamanon, W., & Charatcharoenwitthaya, P. (2023) · Liver International · doi:10.1111/liv.15758 · Cited by 3
Srnic, N., Dearlove, D., Johnson, E. M., MacLeod, C., Krupa, A., McGonnell, A., Frazer-Morris, C., O’Rourke, P., Parry, S. A., & Hodson, L. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.08.028 · Cited by 3
Hedayati, S., Doustmohammadian, A., Jambarsang, S., Maadi, M., Zamani, F., & Hosseinzadeh, M. (2025) · Digestive and Liver Disease · doi:10.1016/j.dld.2025.04.001 · Cited by 3
Pathophysiology and clinical management of non-alcoholic fatty liver disease
Mouralidarane, A., Oben, J. A., & Soeda, J. (2011) · Medicine · doi:10.1016/j.mpmed.2011.07.014 · Cited by 5
Rejeb, J., Omezzine, A., Boumaiza, I., Rebhi, L., Kchock, K., Kalboussi, N., Rejeb, N. B., Nabli, N., Abdelaziz, A. B., Boughzala, E., et al. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0077 · Cited by 3
Insulin resistance and “Lipotoxic Liver Diseases”
Ahammed, S. K. M., & Chowdhury, A. (2013) · Tropical Gastroenterology · doi:10.7869/tg.2012.82 · Cited by 3
Metadata
- Authors
- Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M.
- Affiliations
- Azienda Ospedaliero Universitaria San Giovanni Battista (IT)
- University of Pisa (IT)
- Corresponding author
- Bugianesi, E.
- Venue
- Diabetologia
- Published
- 2005-03-04
- Volume
- 48
- Issue
- 4
- Pages
- 634-642
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1975388439
- Cited by
- 770
- References
- 63
- Citations by year
- 2026: 19 · 2025: 28 · 2024: 42 · 2023: 48 · 2022: 47 · 2021: 48 · 2020: 51 · 2019: 40 · 2018: 43 · 2017: 46 · 2016: 49 · 2015: 37 · 2014: 40 · 2013: 35 · 2012: 32
- FWCI
- 17.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- non-alcoholic fatty liver disease, insulin resistance, glucose oxidation, hepatic glycogen synthesis, lipid oxidation, hepatic steatosis, adipose tissue, non-diabetic patients
- MeSH terms
- Adipose Tissue, Adult, Blood Glucose, Body Composition, C-Peptide, Calorimetry, Indirect, Enzymes, Fasting, Fatty Acids, Nonesterified, Fatty Liver, Glucose, Glycerol, Humans, Insulin, Insulin Resistance, Lipids, Lipoproteins, LDL, Liver, Male, Middle Aged, Oxidation-Reduction, Glucose Clamp Technique, 3-Hydroxybutyric Acid, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.